Measuring Beryllium in Blood and Serum
Author Information
Author(s): Stephan Chadi H, Fournier Michel, Brousseau Pauline, Sauvé Sébastien
Primary Institution: Université de Montréal
Hypothesis
A routine method for the quantification of beryllium in biological fluids is essential for the development of a chelation therapy for Chronic Beryllium Disease (CBD).
Conclusion
The study found that beryllium concentrations are higher in blood than in serum, with a detection limit of 2 to 7 ng L-1.
Supporting Evidence
- The method detection limit was 2 ng l-1 in serum and 7 ng l-1 in blood.
- Beryllium concentrations in blood varied from 0.48 to 0.74 μg L-1.
- The accuracy of the method ranged from 95 to 100%.
Takeaway
This study shows how to measure beryllium in blood and serum, which is important for understanding health risks related to beryllium exposure.
Methodology
The method involved diluting blood and serum samples and using graphite furnace atomic absorption spectrometry to measure beryllium concentrations.
Potential Biases
Potential bias due to the limited demographic diversity of participants.
Limitations
The study's sample size was small and may not represent the general population.
Participant Demographics
10 individuals (8 females and 2 males) with no previous history of occupational exposure to beryllium.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website